Vident Advisory, LLC
- SEC CIK
- 0001744347
- Latest filing
- Aug 12, 2026
SRPT holding history
Sarepta Therapeutics, Inc. in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −10,642−100.0% | Sold out | Holders |
| Q1 2026 | 10,642 | $231.6K | <0.1% | −1,913−15.2% | Reduced | Holders |
| Q4 2025 | 12,555 | $270.2K | <0.1% | −8,301−39.8% | Reduced | Holders |
| Q3 2025 | 20,856 | $401.9K | <0.1% | +20,856 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −3,748−100.0% | Sold out | Holders |
| Q1 2025 | 3,748 | $239.2K | <0.1% | +815+27.8% | Added | Holders |
| Q4 2024 | 2,933 | $356.6K | <0.1% | +2,933 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −2,100−100.0% | Sold out | Holders |
| Q2 2024 | 2,100 | $331.8K | <0.1% | −19−0.9% | Reduced | Holders |
| Q1 2024 | 2,119 | $274.3K | <0.1% | −180−7.8% | Reduced | Holders |
| Q4 2023 | 2,299 | $221.7K | <0.1% | +265+13.0% | Added | Holders |
| Q3 2023 | 2,034 | $246.6K | <0.1% | – | No prior filing | Holders |